Stocks to Watch:

India's rejection of drug patent could re

India's rejection of drug patent could reverberate
Associated Press

A cameraman films the head office of Novartis India Limited in Mumbai, India, Monday, April 1, 2013. India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent a new version of a cancer drug Glivec, in a landmark decision that healthcare activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines. (AP Photo/Rafiq Maqbool)

View Comments